Lidocaine as a potential therapeutic option for super-refractory status epilepticus: A case report

New-onset refractory status epilepticus (NORSE) is a rare and devastating condition and the prognosis is often poor, with half to two-thirds of survivors experiencing drug-resistant epilepsy, residual cognitive impairment, or functional disability, and the mortality rate is 16% to 27% for adults. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugata, Mayu, Kataoka, Hiroshi, Uchihara, Yuto, Shimada, Daisuke, Atagi, Kazuaki, Nakamura, Michitaka, Hara, Makoto, Kawahara, Makoto, Sugie, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492485/
https://www.ncbi.nlm.nih.gov/pubmed/37692459
http://dx.doi.org/10.1177/11795735231200740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492485/
https://www.ncbi.nlm.nih.gov/pubmed/37692459
http://dx.doi.org/10.1177/11795735231200740

Ejemplares similares